Theoretical and experimental epitope mapping of thymosin beta 4.
Becker. S S; Armbruster. F P FP; Müller. B B; Echner. H H; Kapurnotu. A A; Livaniou. E E; Mihelić. M M; Stoeva. S S; Voelter. W W
Key Findings
- Full‑length thymosin‑beta‑4 antisera recognized three separate epitopes (N‑terminal, middle, C‑terminal).
- Antisera raised against the 1‑14 fragment only recognized the N‑terminal epitope.
- Experimental epitope mapping matched theoretical predictions.
Practical Outcomes
- This study is basic science and doesn’t give any actionable advice for dosing, safety, or performance benefits of thymosin‑beta‑4. Biohackers won’t gain useful protocols from it.
Summary
The paper simply maps which parts of the thymosin‑beta‑4 peptide are recognized by antibodies in rabbits, showing that the full‑length peptide triggers antibodies to three regions while a short fragment only triggers the front part. It doesn’t provide any health‑related data or guidance on using the peptide.
Abstract
Two rabbit polyclonal antisera, one directed against thymosin beta 4 and the other one against the peptide fragment thymosin beta 4 (1-14) were characterised by epitope mapping. Hexapeptides representing the whole sequence of the native peptide and overlapping by one amino acid were synthesised on polystyrene pins. The antigenic determinants were identified in microtitre plates with an ELISA procedure. The polyclonal serum against thymosin beta 4 detected three epitopes (N-terminal, mid-region and C-terminal) whereas the polyclonal serum against the fragment contained only antibodies specific for the N-terminal epitope. These experimental results are consistent with theoretical predictions.
Study Information
pubmed
1994
1994-12-28T00:00:00.000Z
10.1016/0022-1759(94)90150-3
7
12